BioTuring and 10x Genomics Partner to Accelerate Spatial Data Insights
SAN DIEGO, CALIFORNIA | January 26, 2026 — BioTuring and 10x Genomics, a global leader in single cell and...
Alzheimer’s Disease Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody NSCLC Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
SAN DIEGO, CALIFORNIA | January 26, 2026 — BioTuring and 10x Genomics, a global leader in single cell and...
RAHWAY, New Jersey | January 7, 2026 — Merck has completed its acquisition of Cidara Therapeutics, marking a significant...
BRISBANE, California | January 7, 2026 — CareDx and 10x Genomics have announced the launch of ImmuneScape™, a multiomics...
